As ACT using T cells essentially requires prior lymphodepletion [5], we first examined the anti-tumor effects of the Fc fusion protein of IL-7 (IL7-Fc) under none, mild, and severe lymphopenic conditions. The gene discussed is IL7; the disease is neoplasm.